Search research articles
Contact Us
Filters
Showing results (91-100 of 161) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma
Vincenzo Damiano, Davide Melisi, Cataldo Bianco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
James A Bonner, Jordi Giralt, Paul M Harari, et al.
American Journal of Clinical Oncology
|
March 25, 2009
Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy
Christine C Olsen, Tracey E Schefter, Honglin Chen, et al.
Molecular Cancer Therapeutics
|
August 10, 2004
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model
David Raben, Cataldo Bianco, Vincenzo Damiano, et al.
Communications Biology
|
August 26, 2021
Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma
Alexander A Strait, Rachel A Woolaver, Spencer C Hall, et al.
Practical Radiation Oncology
|
September 18, 2016
Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial
D Nathan Kim, Christopher Straka, L Chinsoo Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2018
Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers
Shilpa Bhatia, Jaspreet Sharma, Sanjana Bukkapatnam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer
Changhu Chen, Madeleine Kane, John Song, et al.
Clinical Lung Cancer
|
February 24, 2015
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533
Antoinette J Wozniak, James Moon, Charles R Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2011
Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells
Marianne E Marshall, Trista K Hinz, Scott A Kono, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 161) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma
Vincenzo Damiano, Davide Melisi, Cataldo Bianco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
James A Bonner, Jordi Giralt, Paul M Harari, et al.
American Journal of Clinical Oncology
|
March 25, 2009
Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy
Christine C Olsen, Tracey E Schefter, Honglin Chen, et al.
Molecular Cancer Therapeutics
|
August 10, 2004
Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model
David Raben, Cataldo Bianco, Vincenzo Damiano, et al.
Communications Biology
|
August 26, 2021
Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma
Alexander A Strait, Rachel A Woolaver, Spencer C Hall, et al.
Practical Radiation Oncology
|
September 18, 2016
Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial
D Nathan Kim, Christopher Straka, L Chinsoo Cho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 2018
Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers
Shilpa Bhatia, Jaspreet Sharma, Sanjana Bukkapatnam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer
Changhu Chen, Madeleine Kane, John Song, et al.
Clinical Lung Cancer
|
February 24, 2015
A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533
Antoinette J Wozniak, James Moon, Charles R Thomas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2011
Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells
Marianne E Marshall, Trista K Hinz, Scott A Kono, et al.
Page
of 17